-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BIPH7nkZuHaWGdpk/Sfyk8Kxhv95f47eRgr0Fc6nYaJRVpmlxfoihqSvVDAXywmF BURP3wDzvCvM81qxHMnK+w== 0000950130-96-003944.txt : 19961018 0000950130-96-003944.hdr.sgml : 19961018 ACCESSION NUMBER: 0000950130-96-003944 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19961015 ITEM INFORMATION: Other events FILED AS OF DATE: 19961017 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: ROBERTS PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0000853022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222429994 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10432 FILM NUMBER: 96644542 BUSINESS ADDRESS: STREET 1: MERIDIAN CENTRE II STREET 2: 4 INDUSTRIAL WAY W CITY: EATONTOWN STATE: NJ ZIP: 07724 BUSINESS PHONE: 9083891182 MAIL ADDRESS: STREET 1: MERIDIAN CTR II STREET 2: 4 INDUSTRIAL WAY WEST CITY: EATONTOWN STATE: NJ ZIP: 07724 8-K 1 FORM 8-K FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): October 15, 1996 ROBERTS PHARMACEUTICAL CORPORATION - -------------------------------------------------------------------------------- (exact name of registrant as specified in its charter) New Jersey 1-1-432 22-2429994 - ------------------ ----------------- --------------- (State or other (Commission (IRS Employer jurisdiction of File Number) Identification incorporation) Number) Meridian Center II 4 Industrial Way West Eatontown, New Jersey 07724 - -------------------------------------------------------------------------------- (Address of principal executive offices, including zip code) Registrant's telephone number, including area code: 908-389-1182 Meridian Center II 4 Industrial Way West Eatontown, New Jersey 07724 - ------------------------------------------------------------------------------- (Former name or former address, if changed from last report) - 2 - Item 5. Other Events ------------ Roberts Pharmaceutical Corporation announced today that it has agreed in principle to acquire a fully-equipped pharmaceutical manufacturing facility from Searle Canada, a unit of Monsanto Canada Inc. Finalization of the purchase is expected in early 1997. The 100,852 square foot facility located in Oakville, Ontario is approved by both the U.S. Food and Drug Administration and the Health Protection Branch of Canada. In addition to manufacturing and packaging, the Oakville facility includes laboratory (QC/QA), warehouse, and administrative space. The transfer of product manufacturing from third-party manufacturers to its own production facility is a natural evolution in Roberts growth and should, in time, result in substantial cost savings through reduced cost of goods, lower levels of inventory, and the integration of Roberts Pharmaceutical Canada from its leased space in Mississauga, Ontario to the Oakville site. Upon finalizing the purchase, Searle has agreed in principle to lease back space for a time. Searle has also agreed in principle to have Roberts fulfill certain of Searle's product packaging requirements which are currently being met by the Oakville facility. Contract manufacturing by Roberts of other Searle products may be negotiated prior to the transfer of the plant's ownership. In addition, Roberts may consider contract manufacturing for other pharmaceutical companies. Also, Roberts will examine the possibility of cost savings that may arise from the potential consolidation of its distribution channels for finished goods into the Oakville site. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ROBERTS PHARMACEUTICAL CORPORATION ---------------------------------- (Registrant) Date: October 17, 1996 By: /s/ Anthony A. Rascio ------------------------------- Anthony A. Rascio Vice President -----END PRIVACY-ENHANCED MESSAGE-----